rs141400587
Positions:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_003282.4(TNNI2):c.354G>A(p.Ser118Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000428 in 1,613,224 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0024 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 0 hom. )
Consequence
TNNI2
NM_003282.4 synonymous
NM_003282.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -8.22
Genes affected
TNNI2 (HGNC:11946): (troponin I2, fast skeletal type) This gene encodes a fast-twitch skeletal muscle protein, a member of the troponin I gene family, and a component of the troponin complex including troponin T, troponin C and troponin I subunits. The troponin complex, along with tropomyosin, is responsible for the calcium-dependent regulation of striated muscle contraction. Mouse studies show that this component is also present in vascular smooth muscle and may play a role in regulation of smooth muscle function. In addition to muscle tissues, this protein is found in corneal epithelium, cartilage where it is an inhibitor of angiogenesis to inhibit tumor growth and metastasis, and mammary gland where it functions as a co-activator of estrogen receptor-related receptor alpha. This protein also suppresses tumor growth in human ovarian carcinoma. Mutations in this gene cause myopathy and distal arthrogryposis type 2B. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 11-1841108-G-A is Benign according to our data. Variant chr11-1841108-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 167735.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=3}.
BP7
Synonymous conserved (PhyloP=-8.23 with no splicing effect.
BS2
High AC in GnomAd4 at 358 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNNI2 | NM_003282.4 | c.354G>A | p.Ser118Ser | synonymous_variant | 7/8 | ENST00000381911.6 | NP_003273.1 | |
TNNI2 | NM_001145829.2 | c.354G>A | p.Ser118Ser | synonymous_variant | 7/8 | NP_001139301.1 | ||
TNNI2 | NM_001145841.2 | c.354G>A | p.Ser118Ser | synonymous_variant | 5/6 | NP_001139313.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNNI2 | ENST00000381911.6 | c.354G>A | p.Ser118Ser | synonymous_variant | 7/8 | 2 | NM_003282.4 | ENSP00000371336.1 | ||
TNNI2 | ENST00000252898.11 | c.354G>A | p.Ser118Ser | synonymous_variant | 6/7 | 3 | ENSP00000252898.7 | |||
TNNI2 | ENST00000381905.3 | c.354G>A | p.Ser118Ser | synonymous_variant | 5/6 | 3 | ENSP00000371330.3 | |||
TNNI2 | ENST00000381906.5 | c.354G>A | p.Ser118Ser | synonymous_variant | 7/8 | 3 | ENSP00000371331.1 |
Frequencies
GnomAD3 genomes AF: 0.00235 AC: 357AN: 152216Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
357
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000545 AC: 136AN: 249566Hom.: 0 AF XY: 0.000391 AC XY: 53AN XY: 135440
GnomAD3 exomes
AF:
AC:
136
AN:
249566
Hom.:
AF XY:
AC XY:
53
AN XY:
135440
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000227 AC: 332AN: 1460890Hom.: 0 Cov.: 34 AF XY: 0.000190 AC XY: 138AN XY: 726774
GnomAD4 exome
AF:
AC:
332
AN:
1460890
Hom.:
Cov.:
34
AF XY:
AC XY:
138
AN XY:
726774
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00235 AC: 358AN: 152334Hom.: 2 Cov.: 33 AF XY: 0.00238 AC XY: 177AN XY: 74484
GnomAD4 genome
AF:
AC:
358
AN:
152334
Hom.:
Cov.:
33
AF XY:
AC XY:
177
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 01, 2013 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 07, 2014 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 26, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
TNNI2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 22, 2023 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at